Terms: = Head and neck cancer AND BCL10, CIPER, 8915, ENSG00000142867, c-E10, CARMEN, mE10, CLAP
17 results:
1. A quantitative assessment of the number of disease foci in papillary thyroid cancer.
Evans Harding N; Simo R; Li L; Maniam P; Adamson R; Hay A; Conn B; Lyall M; Nixon IJ
Eur J Surg Oncol; 2023 Jul; 49(7):1141-1146. PubMed ID: 37024371
[TBL] [Abstract] [Full Text] [Related]
2. DPP3 expression promotes cell proliferation and migration
Liu JK; Abudula A; Yang HT; Xu LX; Nuerrula Y; Bai G; Tulahong A; Eli M
Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36382663
[TBL] [Abstract] [Full Text] [Related]
3. Risk for a second primary hypopharyngeal and esophageal cancer after an initial primary oral cancer.
Su WW; Chuang SL; Yen AM; Chen SL; Fann JC; Chiu SY; Chiu HM; Su CW; Hsu CY; Chen MK; Chen HH; Wang CP; Lee YC
Oral Dis; 2019 May; 25(4):1067-1075. PubMed ID: 30821883
[TBL] [Abstract] [Full Text] [Related]
4. Accurate, robust and harmonized implementation of morpho-functional imaging in treatment planning for personalized radiotherapy.
Jiménez-Ortega E; Ureba A; Baeza JA; Barbeiro AR; Balcerzyk M; Parrado-Gallego Á; Wals-Zurita A; García-Gómez FJ; Leal A
PLoS One; 2019; 14(1):e0210549. PubMed ID: 30625230
[TBL] [Abstract] [Full Text] [Related]
5. MCTP system model based on linear programming optimization of apertures obtained from sequencing patient image data maps.
Ureba A; Salguero FJ; Barbeiro AR; Jimenez-Ortega E; Baeza JA; Miras H; Linares R; Perucha M; Leal A
Med Phys; 2014 Aug; 41(8):081719. PubMed ID: 25086529
[TBL] [Abstract] [Full Text] [Related]
6. B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway.
Wu TS; Tan CT; Chang CC; Lin BR; Lai WT; Chen ST; Kuo MY; Rau CL; Jaw FS; Chang HH
Oncogene; 2015 Mar; 34(10):1207-19. PubMed ID: 24681956
[TBL] [Abstract] [Full Text] [Related]
7. T(14;18)(q32;q21) involving MALT1 and IGH genes occurs in extranodal diffuse large B-cell lymphomas of the breast and testis.
Kuper-Hommel MJ; Schreuder MI; Gemmink AH; van Krieken JH
Mod Pathol; 2013 Mar; 26(3):421-7. PubMed ID: 23018871
[TBL] [Abstract] [Full Text] [Related]
8. CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/bcl10/Malt1 complex.
Rehman AO; Wang CY
Int J Oral Sci; 2009 Sep; 1(3):105-18. PubMed ID: 20695076
[TBL] [Abstract] [Full Text] [Related]
9. Expression of CARD6, an NF-kappaB activator, in gastric, colorectal and oesophageal cancers.
Kim SS; Ahn CH; Kang MR; Kim YR; Kim HS; Yoo NJ; Lee SH
Pathology; 2010 Jan; 42(1):50-3. PubMed ID: 20025480
[TBL] [Abstract] [Full Text] [Related]
10. [Clinicopathologic characteristics and chromosomal abnormalities in salivary mucosa associated lymphoid tissue lymphomas].
Li BZ; Yu CJ; Xu JJ; Lu HF; Shi DR
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Aug; 44(8):651-6. PubMed ID: 19961773
[TBL] [Abstract] [Full Text] [Related]
11. Pediatric mucosa-associated lymphoid tissue (MALT) lymphoma of lip: a case report and literature review.
Ryu M; Han S; Che Z; Min Y; Yoo KH; Koo HH; Yang WI; Kim HS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Mar; 107(3):393-7. PubMed ID: 19121958
[TBL] [Abstract] [Full Text] [Related]
12. Expression of bcl10 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Chang HH; Kuo MY; Cheng SJ; Chiang CP
Oral Oncol; 2009 Jul; 45(7):589-93. PubMed ID: 18952491
[TBL] [Abstract] [Full Text] [Related]
13. MALT1, bcl10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
Borovecki A; Korac P; Ventura RA; Perisa MM; Banham AH; Dominis M
Pathol Int; 2007 Jan; 57(1):47-51. PubMed ID: 17199743
[TBL] [Abstract] [Full Text] [Related]
14. Lack of bcl10 gene mutations in laryngeal squamous cell carcinoma.
Ronchetti D; Intini D; Pruneri G; Neri A; Pignataro L
J Laryngol Otol; 2002 Aug; 116(8):610-2. PubMed ID: 12389689
[TBL] [Abstract] [Full Text] [Related]
15. Point mutations and deletions of the bcl10 gene in solid tumors and malignant lymphomas.
Lee SH; Shin MS; Kim HS; Park WS; Kim SY; Lee HK; Park JY; Oh RR; Jang JJ; Park KM; Han JY; Kang CS; Lee JY; Yoo NJ
Cancer Res; 1999 Nov; 59(22):5674-7. PubMed ID: 10582682
[TBL] [Abstract] [Full Text] [Related]
16. bcl10 is not a target for frequent mutation in human carcinomas.
Lambers AR; Gumbs C; Ali S; Marks JR; Iglehart JD; Berchuck A; Futreal PA
Br J Cancer; 1999 Jul; 80(10):1575-6. PubMed ID: 10408401
[TBL] [Abstract] [Full Text] [Related]
17. bcl10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital Collaborators.
Gill S; Broni J; Jefferies S; Osin P; Kovacs G; Maitland NJ; Eeles R; Edwards SM; Dyer MJ; Willis TG; Cooper CS
Br J Cancer; 1999 Jul; 80(10):1565-8. PubMed ID: 10408398
[TBL] [Abstract] [Full Text] [Related]
